Meta analysis on TUBEX | IDL Biotech
IDL Biotech

CLOSE MENU

Articles

Typhiod fever

December 2019

Meta analysis on TUBEX

Achieving accurate laboratory diagnosis of typhoid fever: a review and meta-analysis of TUBEX® TF clinical performance.

Read the article here: 

 

Read the press release here:

Gunnar Wahlberg appointed as acting CEO

The Board has appointed Gunnar Wahlberg as acting CEO.

Charlotte Berg leaves the position as CEO of IDL Biotech AB (publ)

IDL Biotech's CEO, Charlotte Berg, has informed the Board that, after more than ten years at the company, she wishes to resign as CEO to start another assignment in a non-competing company.

IDL Biotech

Skip this intro